ALB and chronic kidney disease: This trial randomized 4401 patients with CKD (eGFR) of 30 to <90 ml/min/1.73 m2 of body surface area and type 2 diabetes who had evidence of albuminuria [ratio of albumin (mg) to creatinine (g), >300 to 5000] and were treated with the renin‐angiotensin system blockade.